Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Vincristine"" wg kryterium: Temat


Tytuł:
Concurrent application of interferon-gamma and vincristine inhibits tumor growth in an orthotopic neuroblastoma mouse model.
Autorzy:
Zeki J; Department of Surgery, Stanford University, 453 Quarry Road, Palo Alto, CA, 94304, USA.
Yavuz B; Department of Biomedical Engineering, Tufts University, 4 Colby Street, Medford, MA, 02155, USA.
Wood L; Department of Surgery, Stanford University, 453 Quarry Road, Palo Alto, CA, 94304, USA.
Shimada H; Department of Pathology, Stanford University, Stanford, CA, USA.
Kaplan DL; Department of Biomedical Engineering, Tufts University, 4 Colby Street, Medford, MA, 02155, USA. .
Chiu B; Department of Surgery, Stanford University, 453 Quarry Road, Palo Alto, CA, 94304, USA. .
Pokaż więcej
Źródło:
Pediatric surgery international [Pediatr Surg Int] 2023 Jul 27; Vol. 39 (1), pp. 241. Date of Electronic Publication: 2023 Jul 27.
Typ publikacji:
Journal Article
MeSH Terms:
Interferon-gamma*/therapeutic use
Neuroblastoma*/drug therapy
Neuroblastoma*/pathology
Vincristine*/therapeutic use
Animals ; Humans ; Mice ; Biocompatible Materials ; Disease Models, Animal ; Mice, Inbred C57BL ; Silk
Czasopismo naukowe
Tytuł:
Beneficial effects of quercetin on vincristine-induced liver injury in rats: Modulating the levels of Nrf2/HO-1, NF-kB/STAT3, and SIRT1/PGC-1α.
Autorzy:
Çomaklı S; Department of Pathology, Faculty of Veterinary Medicine, Atatürk University, Erzurum, Turkey.
Özdemir S; Department of Genetics, Faculty of Veterinary Medicine, Atatürk University, Erzurum, Turkey.
Küçükler S; Department of Biochemistry, Faculty of Veterinary Medicine, Atatürk University, Erzurum, Turkey.
Kandemir FM; Department of Biochemistry, Faculty of Medicine, Aksaray University, Aksaray, Turkey.
Pokaż więcej
Źródło:
Journal of biochemical and molecular toxicology [J Biochem Mol Toxicol] 2023 May; Vol. 37 (5), pp. e23326. Date of Electronic Publication: 2023 Feb 19.
Typ publikacji:
Journal Article
MeSH Terms:
Vincristine*/adverse effects
Chemical and Drug Induced Liver Injury*/blood
Chemical and Drug Induced Liver Injury*/drug therapy
Chemical and Drug Induced Liver Injury*/veterinary
Quercetin*/administration & dosage
Antineoplastic Agents, Phytogenic*/adverse effects
Animals ; Rats ; Male ; Rats, Sprague-Dawley ; Liver/chemistry ; Liver/enzymology ; Liver/pathology ; Caspase 3/metabolism ; bcl-2-Associated X Protein/metabolism ; Proto-Oncogene Proteins c-bcl-2/metabolism
Czasopismo naukowe
Tytuł:
Effect of proteasome inhibitors on canine lymphoma cell response to CHOP chemotherapy in vitro.
Autorzy:
Prevedel NE; Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada.
Mee MW; Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada.
Wood GA; Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada.
Coomber BL; Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada.
Pokaż więcej
Źródło:
Veterinary and comparative oncology [Vet Comp Oncol] 2024 Mar; Vol. 22 (1), pp. 96-105. Date of Electronic Publication: 2024 Jan 18.
Typ publikacji:
Journal Article
MeSH Terms:
Dog Diseases*/drug therapy
Lymphoma*/drug therapy
Lymphoma*/veterinary
Boron Compounds*
Glycine/*analogs & derivatives
Humans ; Animals ; Dogs ; Proteasome Inhibitors/pharmacology ; Proteasome Inhibitors/therapeutic use ; Bortezomib/pharmacology ; Bortezomib/therapeutic use ; Vincristine/pharmacology ; Vincristine/therapeutic use ; Proteasome Endopeptidase Complex ; Cyclophosphamide/pharmacology ; Cyclophosphamide/therapeutic use ; Prednisone/pharmacology ; Prednisone/therapeutic use ; Doxorubicin/pharmacology ; Doxorubicin/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Czasopismo naukowe
Tytuł:
Compression therapy using surgical gloves is ineffective for the prevention of vincristine-induced neuropathy in patients with malignant lymphoma.
Autorzy:
Suyama T; Diabetes and Hematology Division, NHO Kanmon Medical Center, 1-1, Sotouracho, Shimonoseki-City, Yamaguchi, 752-8510, Japan. .
Tsuboi Y; Hematology and Oncology Division, Hitachi General Hospital, 2-1-1 Jonancho, Hitachi-City, Ibaraki, 317-0077, Japan.
Shimizu M; Hematology and Oncology Division, Hitachi General Hospital, 2-1-1 Jonancho, Hitachi-City, Ibaraki, 317-0077, Japan.
Kuroda A; Hematology and Oncology Division, Hitachi General Hospital, 2-1-1 Jonancho, Hitachi-City, Ibaraki, 317-0077, Japan.
Seki M; Hematology and Oncology Division, Hitachi General Hospital, 2-1-1 Jonancho, Hitachi-City, Ibaraki, 317-0077, Japan.
Shinagawa A; Hematology and Oncology Division, Hitachi General Hospital, 2-1-1 Jonancho, Hitachi-City, Ibaraki, 317-0077, Japan.
Pokaż więcej
Źródło:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2024 Feb 20; Vol. 32 (3), pp. 173. Date of Electronic Publication: 2024 Feb 20.
Typ publikacji:
Journal Article
MeSH Terms:
Peripheral Nervous System Diseases*/chemically induced
Peripheral Nervous System Diseases*/prevention & control
Peripheral Nervous System Diseases*/drug therapy
Lymphoma, Large B-Cell, Diffuse*/drug therapy
Humans ; Vincristine ; Gloves, Surgical ; Rituximab/adverse effects ; Cyclophosphamide ; Doxorubicin/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Prednisone/adverse effects
Czasopismo naukowe
Tytuł:
Alendronate-Grafted Nanoemulsions for Bone-Targeted Vincristine Delivery: Preliminary Studies on Cell and Animal Models.
Autorzy:
Stoppa I; Department of Health Sciences, Interdisciplinary Research Center of Autoimmune Diseases (IRCAD), University of Eastern Piedmont (UPO), via Solaroli 17, 28100 Novara, Italy.
Dianzani C; Department of Drug Science and Technology, University of Turin, via Pietro Giuria 9, 10125 Turin, Italy.
Clemente N; Department of Health Sciences, Interdisciplinary Research Center of Autoimmune Diseases (IRCAD), University of Eastern Piedmont (UPO), via Solaroli 17, 28100 Novara, Italy.
Bozza A; Department of Drug Science and Technology, University of Turin, via Pietro Giuria 9, 10125 Turin, Italy.
Bordano V; Department of Drug Science and Technology, University of Turin, via Pietro Giuria 9, 10125 Turin, Italy.
Garelli S; Department of Drug Science and Technology, University of Turin, via Pietro Giuria 9, 10125 Turin, Italy.
Cangemi L; Department of Drug Science and Technology, University of Turin, via Pietro Giuria 9, 10125 Turin, Italy.
Dianzani U; Department of Health Sciences, Interdisciplinary Research Center of Autoimmune Diseases (IRCAD), University of Eastern Piedmont (UPO), via Solaroli 17, 28100 Novara, Italy.
Battaglia L; Department of Drug Science and Technology, University of Turin, via Pietro Giuria 9, 10125 Turin, Italy.; Nanostructured Interfaces and Surfaces (NIS) Interdepartmental Centre, University of Turin, 10124 Turin, Italy.
Pokaż więcej
Źródło:
Biomolecules [Biomolecules] 2024 Feb 18; Vol. 14 (2). Date of Electronic Publication: 2024 Feb 18.
Typ publikacji:
Journal Article
MeSH Terms:
Alendronate*/pharmacology
Diphosphonates*/therapeutic use
Animals ; Vincristine/pharmacology ; Bone and Bones ; Models, Animal
Czasopismo naukowe
Tytuł:
Model-Informed Precision Dosing to Reduce Vincristine-Induced Peripheral Neuropathy in Pediatric Patients: A Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis.
Autorzy:
Centanni M; Department of Pharmacy, Uppsala University, Box 580, 751 23, Uppsala, Sweden.
van de Velde ME; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Pediatric Oncology, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Uittenboogaard A; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Pediatric Oncology, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Kaspers GJL; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Pediatric Oncology, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Karlsson MO; Department of Pharmacy, Uppsala University, Box 580, 751 23, Uppsala, Sweden.
Friberg LE; Department of Pharmacy, Uppsala University, Box 580, 751 23, Uppsala, Sweden. .
Pokaż więcej
Źródło:
Clinical pharmacokinetics [Clin Pharmacokinet] 2024 Feb; Vol. 63 (2), pp. 197-209. Date of Electronic Publication: 2023 Dec 23.
Typ publikacji:
Journal Article
MeSH Terms:
Peripheral Nervous System Diseases*/chemically induced
Peripheral Nervous System Diseases*/genetics
Child ; Humans ; Vincristine/adverse effects ; Vincristine/pharmacokinetics ; Area Under Curve ; Genotype ; Drug Monitoring
Czasopismo naukowe
Tytuł:
High monocytic MDSC signature predicts multi-drug resistance and cancer relapse in non-Hodgkin lymphoma patients treated with R-CHOP.
Autorzy:
Dhar S; Department of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, India.
Chakravarti M; Department of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, India.
Ganguly N; Department of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, India.
Saha A; Department of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, India.
Dasgupta S; Department of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, India.
Bera S; Department of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, India.
Sarkar A; Department of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, India.
Roy K; Cellular Immunology and Experimental Therapeutics Laboratory, Department of Zoology, West Bengal State University, Barasat, India.
Das J; Department of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, India.
Bhuniya A; Department of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, India.
Ghosh S; Department of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, India.
Sarkar M; Department of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, India.
Hajra S; Department of Pathology, Chittaranjan National Cancer Institute, Kolkata, India.
Banerjee S; Department of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, India.
Pal C; Cellular Immunology and Experimental Therapeutics Laboratory, Department of Zoology, West Bengal State University, Barasat, India.
Saha B; Department of Pathogenesis and Cell Responses, National Centre for Cell Science, Pune, Maharashtra, India.
Mukherjee KK; Department of Medical Oncology, Chittaranjan National Cancer Institute, Kolkata, India.
Baral R; Department of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, India.
Bose A; Department of Immunoregulation and Immunodiagnostics, Chittaranjan National Cancer Institute, Kolkata, India.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Jan 18; Vol. 14, pp. 1303959. Date of Electronic Publication: 2024 Jan 18 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Myeloid-Derived Suppressor Cells*/metabolism
Lymphoma, Non-Hodgkin*/drug therapy
Lymphoma, Non-Hodgkin*/metabolism
Lymphoma*/metabolism
Humans ; Animals ; Mice ; Rituximab/pharmacology ; Rituximab/therapeutic use ; Rituximab/metabolism ; Vincristine/pharmacology ; Vincristine/therapeutic use ; Interleukin-10/metabolism ; Prednisone/pharmacology ; Prednisone/therapeutic use ; Interleukin-6/metabolism ; Neoplasm Recurrence, Local/metabolism ; Cyclophosphamide/pharmacology ; Cyclophosphamide/therapeutic use ; Doxorubicin/pharmacology ; Doxorubicin/therapeutic use ; Doxorubicin/metabolism ; Biomarkers/metabolism ; Drug Resistance, Multiple ; Tumor Microenvironment/physiology
Czasopismo naukowe
Tytuł:
Prevention of vincristine-induced peripheral neuropathy by protecting the endothelial glycocalyx shedding.
Autorzy:
Ohmura K; Department of Neurosurgery, Gifu University Graduate School of Medicine, Gifu, Japan; Department of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu, Japan.
Kinoshita T; Department of Neurosurgery, Ogaki Tokusyukai Hospital, Gifu, Japan.
Tomita H; Department of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu, Japan; Center for One Medicine Innovative Translational Research, Gifu University Institute for Advanced Study, Gifu, Japan. Electronic address: .
Okada H; Center for One Medicine Innovative Translational Research, Gifu University Institute for Advanced Study, Gifu, Japan; Department of Emergency and Disaster Medicine, Gifu University Graduate School of Medicine, Gifu, Japan. Electronic address: .
Shimizu M; Department of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu, Japan.
Mori K; Department of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu, Japan.
Taniguchi T; Department of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu, Japan.
Suzuki A; Department of Pharmacy, Gifu University Hospital, Gifu, Japan.
Iwama T; Department of Neurosurgery, Gifu University Graduate School of Medicine, Gifu, Japan.
Hara A; Department of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu, Japan.
Pokaż więcej
Źródło:
Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2024 Jan 08; Vol. 691, pp. 149286. Date of Electronic Publication: 2023 Nov 21.
Typ publikacji:
Journal Article
MeSH Terms:
Glycocalyx*
Peripheral Nervous System Diseases*/chemically induced
Peripheral Nervous System Diseases*/prevention & control
Humans ; Mice ; Animals ; Vincristine/adverse effects ; Quality of Life
Czasopismo naukowe
Tytuł:
Effects of vincristine and monosodium glutamate on gastrointestinal motility and visceral sensitivity.
Autorzy:
López-Tofiño Y; Department of Basic Health Sciences, University Rey Juan Carlos (URJC), Alcorcón, Spain.; High Performance Research Group in Physiopathology and Pharmacology of the Digestive System (NeuGut), University Rey Juan Carlos (URJC), Alcorcón, Spain.
de Sosa F; Hospital de Fuenlabrada, Fuenlabrada, Spain.
Vera G; Department of Basic Health Sciences, University Rey Juan Carlos (URJC), Alcorcón, Spain.; High Performance Research Group in Physiopathology and Pharmacology of the Digestive System (NeuGut), University Rey Juan Carlos (URJC), Alcorcón, Spain.; Associated I+D+i Unit to the Institute of Medicinal Chemistry (IQM), Scientific Research Superior Council (CSIC), Madrid, Spain.
López-Gómez L; Department of Basic Health Sciences, University Rey Juan Carlos (URJC), Alcorcón, Spain.; High Performance Research Group in Physiopathology and Pharmacology of the Digestive System (NeuGut), University Rey Juan Carlos (URJC), Alcorcón, Spain.
Herradón E; Department of Basic Health Sciences, University Rey Juan Carlos (URJC), Alcorcón, Spain.; Associated I+D+i Unit to the Institute of Medicinal Chemistry (IQM), Scientific Research Superior Council (CSIC), Madrid, Spain.; High Performance Research Group in Experimental Pharmacology (PHARMAKOM), University Rey Juan Carlos (URJC), Alcorcón, Spain.
López-Miranda V; Department of Basic Health Sciences, University Rey Juan Carlos (URJC), Alcorcón, Spain.; Associated I+D+i Unit to the Institute of Medicinal Chemistry (IQM), Scientific Research Superior Council (CSIC), Madrid, Spain.; High Performance Research Group in Experimental Pharmacology (PHARMAKOM), University Rey Juan Carlos (URJC), Alcorcón, Spain.
Nurgali K; Institute for Health and Sport, Victoria University, Melbourne, Victoria, Australia.; Department of Medicine Western Health, The University of Melbourne, Melbourne, Victoria, Australia.; Regenerative Medicine and Stem Cell Program, Australian Institute for Musculoskeletal Science (AIMSS), Melbourne, Victoria, Australia.
Uranga JA; Department of Basic Health Sciences, University Rey Juan Carlos (URJC), Alcorcón, Spain.; High Performance Research Group in Physiopathology and Pharmacology of the Digestive System (NeuGut), University Rey Juan Carlos (URJC), Alcorcón, Spain.
Abalo R; Department of Basic Health Sciences, University Rey Juan Carlos (URJC), Alcorcón, Spain.; High Performance Research Group in Physiopathology and Pharmacology of the Digestive System (NeuGut), University Rey Juan Carlos (URJC), Alcorcón, Spain.; Associated I+D+i Unit to the Institute of Medicinal Chemistry (IQM), Scientific Research Superior Council (CSIC), Madrid, Spain.; Working Group of Basic Sciences on Pain and Analgesia of the Spanish Pain Society, Madrid, Spain.; Working Group of Basic Sciences on Cannabinoids of the Spanish Pain Society, Madrid, Spain.
Pokaż więcej
Źródło:
Neurogastroenterology and motility [Neurogastroenterol Motil] 2024 Jan; Vol. 36 (1), pp. e14704. Date of Electronic Publication: 2023 Nov 14.
Typ publikacji:
Journal Article
MeSH Terms:
Sodium Glutamate*/pharmacology
Gastrointestinal Motility*/physiology
Rats ; Male ; Animals ; Vincristine/pharmacology ; Rats, Wistar ; Cisplatin/pharmacology
Czasopismo naukowe
Tytuł:
Rapid liposomal formulation for nucleolin targeting to rhabdomyosarcoma cells.
Autorzy:
Dzhumashev D; Department of Pediatric Hematology and Oncology, Inselspital, Bern University Hospital, 3010 Bern, Switzerland; Department for BioMedical Research (DBMR), University of Bern, 3008 Bern, Switzerland; Graduate School for Cellular and Biomedical Sciences, University of Bern, 3012 Bern, Switzerland.
Anton-Joseph S; Department of Pediatric Hematology and Oncology, Inselspital, Bern University Hospital, 3010 Bern, Switzerland; Department for BioMedical Research (DBMR), University of Bern, 3008 Bern, Switzerland; Graduate School for Cellular and Biomedical Sciences, University of Bern, 3012 Bern, Switzerland.
Morel VJ; Department of Pediatric Hematology and Oncology, Inselspital, Bern University Hospital, 3010 Bern, Switzerland; Department for BioMedical Research (DBMR), University of Bern, 3008 Bern, Switzerland.
Timpanaro A; Department of Pediatric Hematology and Oncology, Inselspital, Bern University Hospital, 3010 Bern, Switzerland; Department for BioMedical Research (DBMR), University of Bern, 3008 Bern, Switzerland; Graduate School for Cellular and Biomedical Sciences, University of Bern, 3012 Bern, Switzerland.
Bordon G; Department of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, 3012 Bern, Switzerland.
Piccand C; Department of Pediatric Hematology and Oncology, Inselspital, Bern University Hospital, 3010 Bern, Switzerland; Department for BioMedical Research (DBMR), University of Bern, 3008 Bern, Switzerland; Graduate School for Cellular and Biomedical Sciences, University of Bern, 3012 Bern, Switzerland.
Aleandri S; Department of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, 3012 Bern, Switzerland.
Luciani P; Department of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, 3012 Bern, Switzerland.
Rössler J; Department of Pediatric Hematology and Oncology, Inselspital, Bern University Hospital, 3010 Bern, Switzerland; Department for BioMedical Research (DBMR), University of Bern, 3008 Bern, Switzerland.
Bernasconi M; Department of Pediatric Hematology and Oncology, Inselspital, Bern University Hospital, 3010 Bern, Switzerland; Department for BioMedical Research (DBMR), University of Bern, 3008 Bern, Switzerland. Electronic address: .
Pokaż więcej
Źródło:
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V [Eur J Pharm Biopharm] 2024 Jan; Vol. 194, pp. 49-61. Date of Electronic Publication: 2023 Nov 27.
Typ publikacji:
Journal Article
MeSH Terms:
Liposomes*/metabolism
Rhabdomyosarcoma*/drug therapy
Rhabdomyosarcoma*/metabolism
Child ; Humans ; Nucleolin ; Vincristine/therapeutic use ; Cell Line, Tumor ; Peptides/metabolism
Czasopismo naukowe
Tytuł:
Vincristine-based nanoformulations: a preclinical and clinical studies overview.
Autorzy:
Shukla R; Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research-Raebareli, Bijnor-Sisendi Road, Sarojini Nagar, Near CRPF Base Camp, U.P, 226002, Lucknow, India. .
Singh A; Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research-Raebareli, Bijnor-Sisendi Road, Sarojini Nagar, Near CRPF Base Camp, U.P, 226002, Lucknow, India.
Singh KK; School of Pharmacy and Biomedical Sciences, Faculty of Clinical and Biomedical Sciences, University of Central Lancashire, Preston, PR1 2HE, UK. .
Pokaż więcej
Źródło:
Drug delivery and translational research [Drug Deliv Transl Res] 2024 Jan; Vol. 14 (1), pp. 1-16. Date of Electronic Publication: 2023 Aug 08.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Antineoplastic Agents*/therapeutic use
Lung Neoplasms*/drug therapy
Humans ; Vincristine/adverse effects ; Tissue Distribution ; Drug Delivery Systems
Czasopismo naukowe
Tytuł:
Interaction between environmental pollutants and cancer drug efficacy: Bisphenol A, Bisphenol A diglycidyl ether and Perfluorooctanoic acid reduce vincristine cytotoxicity in acute lymphoblastic leukemia cells.
Autorzy:
Lagunas-Rangel FA; Department of Surgical Sciences, Functional Pharmacology and Neuroscience, Uppsala University, Uppsala, Sweden.
Liu W; Department of Surgical Sciences, Functional Pharmacology and Neuroscience, Uppsala University, Uppsala, Sweden.
Schiöth HB; Department of Surgical Sciences, Functional Pharmacology and Neuroscience, Uppsala University, Uppsala, Sweden.
Pokaż więcej
Źródło:
Journal of applied toxicology : JAT [J Appl Toxicol] 2023 Mar; Vol. 43 (3), pp. 458-469. Date of Electronic Publication: 2022 Oct 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antineoplastic Agents*/chemistry
Antineoplastic Agents*/toxicity
Environmental Pollutants*/chemistry
Environmental Pollutants*/toxicity
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Vincristine*/chemistry
Vincristine*/toxicity
Child ; Humans ; Benzhydryl Compounds/toxicity ; Benzhydryl Compounds/analysis ; Epoxy Compounds/toxicity ; Phosphatidylinositol 3-Kinases
Czasopismo naukowe
Tytuł:
In vitro chemosensitivity testing of the feline large granular lymphocyte cell line (S87).
Autorzy:
Hartung S; Faculty of Veterinary Medicine, Institute of Veterinary Pathology, Justus-Liebig-University Giessen, Giessen, Germany.
Herden C; Faculty of Veterinary Medicine, Institute of Veterinary Pathology, Justus-Liebig-University Giessen, Giessen, Germany.
Sparenberg M; Unit for Biomathematics and Data Processing, Faculty of Veterinary Medicine, Justus-Liebig-University Giessen, Giessen, Germany.
Henrich M; Faculty of Veterinary Medicine, Institute of Veterinary Pathology, Justus-Liebig-University Giessen, Giessen, Germany.
Pokaż więcej
Źródło:
Veterinary medicine and science [Vet Med Sci] 2024 Mar; Vol. 10 (2), pp. e1350.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphoma*/drug therapy
Lymphoma*/veterinary
Lymphoma*/pathology
Cat Diseases*
Cyclophosphamide/*analogs & derivatives
Cats ; Animals ; Vincristine ; Asparaginase/therapeutic use ; Methotrexate/therapeutic use ; Doxorubicin/pharmacology ; Cell Line ; Prednisolone/pharmacology ; Prednisolone/therapeutic use ; Lymphocytes/pathology
Czasopismo naukowe
Tytuł:
Navigating between Scylla and Charybdis: A roadmap to do better than Pola-RCHP in DLBCL.
Autorzy:
Munoz J; Department of Hematology, Mayo Clinic Arizona, Phoenix, AZ, USA.
Deshpande A; Mayo Clinic Alix School of Medicine, Scottsdale, AZ, USA. Electronic address: .
Rimsza L; Department of Pathology, Mayo Clinic Arizona, Phoenix, AZ, USA.
Nowakowski GS; Department of Internal Medicine, Division of Hematology, Mayo Clinic College of Medicine and Mayo Foundation, Rochester, MN, USA.
Kurzrock R; Medical College of Wisconsin, Milwaukee, WI, USA; WIN Consortium, Paris, France; University of Nebraska, Omaha, Nebraska, USA.
Pokaż więcej
Źródło:
Cancer treatment reviews [Cancer Treat Rev] 2024 Mar; Vol. 124, pp. 102691. Date of Electronic Publication: 2024 Jan 17.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Lymphoma, Large B-Cell, Diffuse*/drug therapy
Immunoconjugates*/therapeutic use
Humans ; Artificial Intelligence ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Rituximab/therapeutic use ; Vincristine
Czasopismo naukowe
Tytuł:
Treatment of feline intermediate to high-grade alimentary lymphoma: A retrospective evaluation of 55 cats treated with the VAPC combination chemotherapy protocol (2017-2021).
Autorzy:
Moore AS; Veterinary Oncology Consultants, Lake Innes, New South Wales, Australia.
Frimberger AE; Veterinary Oncology Consultants, Lake Innes, New South Wales, Australia.
Pokaż więcej
Źródło:
Veterinary and comparative oncology [Vet Comp Oncol] 2024 Mar; Vol. 22 (1), pp. 106-114. Date of Electronic Publication: 2023 Dec 28.
Typ publikacji:
Journal Article
MeSH Terms:
Lymphoma, Non-Hodgkin*/drug therapy
Lymphoma, Non-Hodgkin*/veterinary
Lymphoma*/drug therapy
Lymphoma*/veterinary
Cat Diseases*/drug therapy
Cats ; Animals ; Vincristine/therapeutic use ; Asparaginase/adverse effects ; Retrospective Studies ; Vinblastine/therapeutic use ; Prednisone/therapeutic use ; Cyclophosphamide/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Doxorubicin/therapeutic use
Czasopismo naukowe
Tytuł:
R-CHOP treatment for patients with advanced follicular lymphoma: Over 15-year follow-up of JCOG0203.
Autorzy:
Watanabe T; Department of Haematology, National Cancer Center Hospital, Tokyo, Japan.
Tobinai K; Department of Haematology, National Cancer Center Hospital, Tokyo, Japan.
Wakabayashi M; JCOG Data Center/Operation Center, National Cancer Center, Tokyo, Japan.
Maruyama D; Department of Haematology, National Cancer Center Hospital, Tokyo, Japan.
Yamamoto K; Department of Haematology and Cell Therapy, Aichi Cancer Center, Nagoya, Japan.
Kubota N; Department of Haematology, Saitama Cancer Center, Saitama, Japan.
Shimada K; Department of Haematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Asagoe K; Department of Haematology and Oncology, Shiga General Hospital, Moriyama, Japan.
Yamaguchi M; Department of Haematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan.
Ando K; Division of Haematology/Oncology, Department of Internal Medicine, Tokai University School of Medicine, Isehara, Japan.
Ogura M; Department of Haematology and Oncology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan.
Kuroda J; Division of Haematology and Oncology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Suehiro Y; Department of Haematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
Matsuno Y; Department of Pathology, National Cancer Center Hospital, Tokyo, Japan.
Tsukasaki K; Department of Haematology, International Medical Center, Saitama Medical University, Moriyama, Japan.
Nagai H; Department of Haematology and Oncology Research National Hospital Organization, Nagoya Medical Center, Nagoya, Japan.
Pokaż więcej
Źródło:
British journal of haematology [Br J Haematol] 2024 Mar; Vol. 204 (3), pp. 849-860. Date of Electronic Publication: 2023 Nov 23.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Lymphoma, Follicular*/drug therapy
Humans ; Rituximab ; Vincristine ; Prednisone ; Follow-Up Studies ; Antibodies, Monoclonal, Murine-Derived/therapeutic use ; Cyclophosphamide ; Doxorubicin ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Treatment practices and response in kaposiform hemangioendothelioma: A multicenter cohort study.
Autorzy:
Borst AJ; Perelman School of Medicine at the University of Pennsylvania/Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Eng W; Harvard Medical School/Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.
Griffin M; Harvard Medical School/Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.
Ricci KW; The University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Engel E; The University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Adams DM; Perelman School of Medicine at the University of Pennsylvania/Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Dayneka J; Perelman School of Medicine at the University of Pennsylvania/Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Tulane School of Medicine/Children's Hospital New Orleans, New Orleans, Louisiana, USA.
Cohen-Cutler SJ; Perelman School of Medicine at the University of Pennsylvania/Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Keck School of Medicine of University of Southern California/Children's Hospital Los Angeles, Los Angeles, California, USA.
Andreoli SM; University of Florida College of Medicine-Jacksonville/Nemours Children's Specialty Care, Jacksonville, Florida, USA.
Wu MD; Oregon Health & Science University, Doernbecher Children's Hospital, Portland, Oregon, USA.
Wheeler AP; Vanderbilt University School of Medicine/Monroe Carell Jr Children's Hospital, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Heym KM; Cook Children's Medical Center, Fort Worth, Texas, USA.
Crary SE; University of Arkansas for Medical Sciences/Arkansas Children's Hospital, Little Rock, Arkansas, USA.
Nakano TA; University of Colorado School of Medicine/Children's Hospital Colorado, Aurora, Colorado, USA.
Schulte RR; Indiana University School of Medicine/Riley Children's Hospital, Indianapolis, Indiana, USA.
Setty BA; Ohio State University College of Medicine/Nationwide Children's Hospital, Columbus, Ohio, USA.
McLean TW; Wake Forest University School of Medicine/Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina, USA.
Pahl KS; Duke University School of Medicine, Duke Children's Hospital, Durham, North Carolina, USA.
Intzes S; Providence Sacred Heart Medical Center and Children's Hospital, Spokane, Washington, USA.
Pateva I; Case Western Reserve University/Rainbow Babies and Children's Hospital, Cleveland, Ohio, USA.
Teitelbaum M; Byram Hills High School, Armonk, New York, USA.
Zong Z; Perelman School of Medicine at the University of Pennsylvania/Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Li Y; Perelman School of Medicine at the University of Pennsylvania/Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Jeng MR; Stanford University School of Medicine/Lucile Packard Children's Hospital, Palo Alto, California, USA.
Pokaż więcej
Źródło:
Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Mar; Vol. 71 (3), pp. e30779. Date of Electronic Publication: 2023 Dec 10.
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
Kasabach-Merritt Syndrome*/drug therapy
Kasabach-Merritt Syndrome*/pathology
Vascular Neoplasms*
Hemangioendothelioma*/drug therapy
Hemangioendothelioma*/pathology
Sarcoma, Kaposi*/pathology
Hemangioma*
Skin Neoplasms*
Child ; Humans ; Vincristine ; Prospective Studies ; Sirolimus/therapeutic use
SCR Disease Name:
Kaposiform Hemangioendothelioma; Tufted angioma
Czasopismo naukowe
Tytuł:
The Impact of Time From Diagnosis to Initiation of Chemotherapy on Survival of Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma in the Veterans Health Administration.
Autorzy:
Roman Souza G; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL. Electronic address: .
Nooruddin Z; University of Texas Health Science Center San Antonio, San Antonio, TX.
Lee S; University of Texas Health Science Center San Antonio, San Antonio, TX.
Boyle L; University of Texas Health Science Center San Antonio, San Antonio, TX.
Lucero KT; University of Texas Health Science Center San Antonio, San Antonio, TX.
Ananth S; Stanford University, Stanford, CA.
Franklin K; South Texas Veterans Health Care System, San Antonio, TX.
Mader M; South Texas Veterans Health Care System, San Antonio, TX.
Toro Velez E; University of Texas Health Science Center San Antonio, San Antonio, TX.
Naqvi A; University of Texas Health Science Center San Antonio, San Antonio, TX.
Kaur S; University of Texas Health Science Center San Antonio, San Antonio, TX.
Pokaż więcej
Źródło:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Mar; Vol. 24 (3), pp. e67-e77. Date of Electronic Publication: 2023 Nov 24.
Typ publikacji:
Journal Article
MeSH Terms:
Veterans Health*
Lymphoma, Large B-Cell, Diffuse*/diagnosis
Lymphoma, Large B-Cell, Diffuse*/drug therapy
Lymphoma, Large B-Cell, Diffuse*/pathology
Humans ; Retrospective Studies ; Cyclophosphamide/therapeutic use ; Vincristine/therapeutic use ; Prednisone/therapeutic use ; Doxorubicin/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Prognosis ; Rituximab/therapeutic use
Czasopismo naukowe
Tytuł:
Primary thyroid lymphoma: a case series.
Autorzy:
Sakhri S; Department of Surgical Oncology, Salah Azaiez Institute, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
Zemni I; Department of Surgical Oncology, Salah Azaiez Institute, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia. .; LMBA (LR03ES03), Sciences Faculty of Tunis, University Tunis El Manar, Tunis, Tunisia. .
Ayadi MA; Department of Surgical Oncology, Salah Azaiez Institute, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.; LMBA (LR03ES03), Sciences Faculty of Tunis, University Tunis El Manar, Tunis, Tunisia.
Kamoun S; Department of Pathology, Salah Azaïz Institute, Faculty of Medicine, University Tunis El Manar, Tunis, Tunisia.
Chargui R; Department of Surgical Oncology, Salah Azaiez Institute, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
Ben Dhiab T; Department of Surgical Oncology, Salah Azaiez Institute, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
Pokaż więcej
Źródło:
Journal of medical case reports [J Med Case Rep] 2024 Feb 24; Vol. 18 (1), pp. 108. Date of Electronic Publication: 2024 Feb 24.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Thyroid Neoplasms*/pathology
Lymphoma, Non-Hodgkin*
Lymphoma, Large B-Cell, Diffuse*/diagnosis
Lymphoma, Large B-Cell, Diffuse*/therapy
Lymphoma, Large B-Cell, Diffuse*/pathology
Male ; Humans ; Female ; Aged ; Rare Diseases ; Doxorubicin/therapeutic use ; Prednisone/therapeutic use ; Vincristine/therapeutic use ; Rituximab ; Cyclophosphamide/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Czasopismo naukowe
Tytuł:
The influence of cytotoxic drugs on the immunophenotype of blast cells in paediatric B precursor acute lymphoblastic leukaemia.
Autorzy:
Prelog T; Department of Haemato-Oncology, University Children's Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia.; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Bucek S; Department of Cytopathology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
Brozic A; Department of Cytopathology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
Peterlin J; Institute for Biostatistics and Medical Informatics, University of Ljubljana, Ljubljana, Slovenia.
Kavcic M; Department of Haemato-Oncology, University Children's Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Omerzel M; Department of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
Markelc B; Department of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
Jesenko T; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.; Department of Experimental Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
Prevodnik VK; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.; Department of Cytopathology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.; Institute of Pathology, Faculty of Medicine University of Maribor, Maribor, Slovenia.
Pokaż więcej
Źródło:
Radiology and oncology [Radiol Oncol] 2024 Feb 21; Vol. 58 (1), pp. 133-144. Date of Electronic Publication: 2024 Feb 21 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy
Antineoplastic Agents*/pharmacology
Antineoplastic Agents*/therapeutic use
Child ; Humans ; Vincristine/pharmacology ; Daunorubicin/pharmacology ; Daunorubicin/therapeutic use ; Prednisolone/pharmacology ; Prednisolone/therapeutic use
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies